Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
56.1M
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$20.4B
-
Value change
-
+$188M
-
Put/Call ratio
-
1.49
-
Number of buys
-
120
-
Number of sells
-
-112
-
Price
-
$363.00
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q3 2021
292 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q3 2021.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.1M shares
of 1.39B outstanding shares and own 4.05% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.7M shares), Capital International Investors (6.32M shares), HHLR ADVISORS, LTD. (5.47M shares), BAILLIE GIFFORD & CO (4.25M shares), FMR LLC (3.81M shares), PRIMECAP MANAGEMENT CO/CA/ (3.81M shares), Invesco Ltd. (3.06M shares), Temasek Holdings (Private) Ltd (2.91M shares), BlackRock Inc. (2.63M shares), and CAPITAL INTERNATIONAL INC /CA/ (1.01M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.